Market Research Report
Global Radiopharmaceuticals Market 2020-2024
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||945143|
|Published||Content info||120 Pages
Delivery time: 1-2 business days
|Global Radiopharmaceuticals Market 2020-2024|
|Published: June 24, 2020||Content info: 120 Pages||
Technavio has been monitoring the radiopharmaceuticals market and it is poised to grow by $ 3.58 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. Our reports on radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising burden of the neurological disorders, growing cancer cases and rising investment in oncology market, and minimal side effects of the radiopharmaceuticals as compared with its potential benefits. In addition, rising burden of the neurological disorders is anticipated to boost the growth of the market as well.
The radiopharmaceuticals market analysis includes application segment and geographic landscapes
Technavio's ‘ radiopharmaceuticals market ’ is segmented as below:
By Geographic Landscape:
This study identifies the partnerships for development of radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, production based on cyclotron will lead to sizable demand in the market.
"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our radiopharmaceuticals market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, BWX Technologies Inc., Cardinal Health Inc., Curium, Eckert & Ziegler AG, Eli Lilly and Co., General Electric Co., Lantheus Holdings Inc., Novartis AG, and Siemens Healthineers AG. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.